Identification of a protein expression signature distinguishing early from organising diffuse alveolar damage in COVID-19 patients
Authors:
Open Access
- 9 March 2023
- journal article
- research article
- Published by BMJ in Journal of Clinical Pathology
- Vol. 76 (8) , 561-565
Abstract
Diffuse alveolar damage (DAD) is the histological expression of acute respiratory distress syndrome and characterises lung pathology due to infection with SARS-CoV-2, and other respiratory pathogens of clinical significance. DAD reflects a time-dependent immunopathological process, progressing from an early/exudative stage through to an organising/fibrotic stage, yet within an individual these different stages of DAD may coexist. Understanding the progression of DAD is central to the development of new therapeutics to limit progressive lung damage. Here, we applied highly multiplexed spatial protein profiling to autopsy lung tissues derived from 27 patients who died from COVID-19 and identified a protein signature (ARG1, CD127, GZMB, IDO1, Ki67, phospho-PRAS40 (T246) and VISTA) that distinguishes early DAD from late DAD with good predictive accuracy. These proteins warrant further investigation as potential regulators of DAD progression.Keywords
All Related Versions
Funding Information
- National Institute for Health Research (MR/V028448, UK Coronavirus Immunology Consortium)
- UK Research and Innovation (MR/V028448, UK Coronavirus Immunology Consortium)
- Wellcome Trust (WT104726)
- Sanger Institute Core Funding (Wellcome Trust)
This publication has 16 references indexed in Scilit:
- The pathogenic role of epithelial and endothelial cells in early-phase COVID-19 pneumonia: victims and partners in crimeLaboratory Investigation, 2021
- The spatial landscape of lung pathology during COVID-19 progressionNature, 2021
- VISTA: A Target to Manage the Innate Cytokine StormFrontiers in Immunology, 2021
- Progression to fibrosing diffuse alveolar damage in a series of 30 minimally invasive autopsies with COVID‐19 pneumonia in Wuhan, ChinaHistopathology, 2020
- Two distinct immunopathological profiles in autopsy lungs of COVID-19Nature Communications, 2020
- Pathological post‐mortem findings in lungs infected with SARS‐CoV‐2The Journal of Pathology, 2020
- Immunohistochemical Evidence for the Association between Attenuated mTOR Signaling and Diffuse Alveolar Damage, A Fatal Lung ComplicationThe Tohoku Journal of Experimental Medicine, 2014
- mTOR Signaling in Growth Control and DiseaseCell, 2012
- ROCR: visualizing classifier performance in RBioinformatics, 2005
- Fas/FasL and perforin/granzyme pathway in acute rejection and diffuse alveolar damage after allogeneic lung transplantation?a human biopsy studyVirchows Archiv, 2004